Diane D Liu Selected Research

Protons (Proton)

1/2021	A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.
1/2021	Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diane D Liu Research Topics

Disease

50	Neoplasms (Cancer) 12/2021 - 05/2002
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 05/2002
13	Breast Neoplasms (Breast Cancer) 11/2021 - 10/2011
10	Lung Neoplasms (Lung Cancer) 12/2019 - 01/2003
8	Neoplasm Metastasis (Metastasis) 10/2021 - 05/2003
7	Pain (Aches) 11/2021 - 01/2018
6	Carcinogenesis 04/2014 - 01/2002
5	Adenocarcinoma of Lung 07/2013 - 01/2009
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2011 - 12/2005
4	Fatigue 12/2021 - 01/2016
4	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 04/2009
4	Carcinoma (Carcinomatosis) 05/2011 - 07/2002
3	Pathologic Complete Response 01/2020 - 10/2011
3	Adenocarcinoma 04/2011 - 04/2009
2	Cancer Pain 01/2021 - 01/2020
2	Dyspnea (Shortness of Breath) 01/2019 - 01/2016
2	Infections 02/2018 - 07/2002
2	Agranulocytosis (Granulocytopenia) 02/2018 - 07/2002
2	Nausea 01/2018 - 12/2015
2	Brain Neoplasms (Brain Tumor) 01/2014 - 05/2009
2	Glioma (Gliomas) 01/2014 - 04/2009
2	Metaplasia 02/2010 - 02/2003
2	Squamous Cell Carcinoma of Head and Neck 06/2007 - 12/2005
1	Long Term Adverse Effects 12/2021
1	Chronic Disease (Chronic Diseases) 11/2021
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021
1	Sarcopenia 01/2021
1	Obesity 01/2021
1	Breast Carcinoma In Situ 01/2020
1	Medulloblastoma 01/2020
1	Hyperplasia 01/2020
1	Circulating Neoplastic Cells 01/2020
1	Poisoning 01/2020
1	Inflammatory Breast Neoplasms 01/2020
1	Ependymoma 01/2020
1	Breakthrough Pain 01/2019
1	Exanthema (Rash) 02/2018
1	Hypokalemia 02/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2018
1	Sepsis (Septicemia) 02/2018

Drug/Important Bio-Agent (IBA)

9	Opioid Analgesics (Opioids)IBA 01/2021 - 12/2017
8	Proteins (Proteins, Gene)FDA Link 04/2014 - 03/2005
6	ErbB Receptors (EGF Receptor)IBA 01/2016 - 04/2005
5	Estrogen ReceptorsIBA 01/2020 - 08/2007
3	Pharmaceutical PreparationsIBA 01/2021 - 05/2011
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2002
3	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2016
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2018 - 04/2005
3	Docetaxel (Taxotere)FDA Link 02/2018 - 04/2009
3	Bevacizumab (Avastin)FDA Link 01/2016 - 04/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2015 - 11/2003
3	Carboplatin (JM8)FDA LinkGeneric 06/2015 - 04/2009
3	Tyrosine Kinase InhibitorsIBA 06/2015 - 04/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2014 - 04/2005
3	Biological ProductsIBA 01/2009 - 12/2002
3	RetinoidsIBA 07/2005 - 02/2003
2	Protons (Proton)IBA 01/2021 - 01/2021
2	Celecoxib (Celebrex)FDA Link 01/2020 - 02/2010
2	Cisplatin (Platino)FDA LinkGeneric 02/2018 - 11/2003
2	Morphine (MS Contin)FDA LinkGeneric 01/2018 - 12/2017
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2018 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2016 - 01/2003
2	Monoclonal AntibodiesIBA 03/2015 - 04/2005
2	Transcription Factors (Transcription Factor)IBA 07/2013 - 08/2008
2	Progesterone Receptors (Progesterone Receptor)IBA 02/2012 - 08/2007
2	Cadherins (E-Cadherin)IBA 05/2009 - 03/2005
2	alpha-Tocopherol FDA Link 01/2009 - 03/2005
2	Cyclin D1IBA 01/2009 - 02/2003
2	Messenger RNA (mRNA)IBA 08/2008 - 09/2002
2	Insulin-Like PeptidesIBA 07/2006 - 07/2005
2	retinoic acid receptor betaIBA 02/2003 - 01/2003
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021
1	talimogene laherparepvecIBA 11/2021
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2021
1	GlutaminaseIBA 01/2021
1	Hormones (Hormone)IBA 01/2020
1	Radium-223IBA 01/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	BenzodiazepinesIBA 12/2019
1	Hypnotics and Sedatives (Sedatives)IBA 12/2019
1	N-acetyltalosaminuronic acid (NAT)IBA 11/2018
1	PlatinumIBA 02/2018
1	C-Reactive ProteinIBA 01/2018
1	InterleukinsIBA 01/2018

Therapy/Procedure

19	Therapeutics 12/2021 - 02/2003
12	Palliative Care (Palliative Therapy) 11/2021 - 01/2017
8	Chemoprevention 01/2021 - 01/2002
7	Radiotherapy 01/2021 - 12/2005
7	Drug Therapy (Chemotherapy) 01/2021 - 05/2010
6	Neoadjuvant Therapy 01/2020 - 10/2011
2	Physical Therapy Modalities (Physical Therapy Technique) 12/2021 - 01/2021
2	Immunotherapy 11/2021 - 01/2011
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 01/2021
2	Perioperative Period 02/2018 - 03/2014
1	Patient Transfer (Patient Dumping) 10/2021
1	Continuity of Patient Care 10/2021
1	Preoperative Exercise 01/2021
1	Intraventricular Infusions 01/2020
1	Precision Medicine 12/2019
1	Electric Stimulation Therapy (Electrotherapy) 01/2018